Windtreetx
Edit

Windtreetx

https://windtreetx.com/
Last activity: 01.07.2021
Active
Categories: BioTechCare
A biotechnology company focused on developing novel KL4 surfactant therapies for respiratory diseases and other potential applications.
Followers
902
Mentions
17
Location: United States, Pennsylvania, Warrington Township
Twitter

Investors 1

Mentions in press and media 17

DateTitleDescription
20.04.2023Windtree Therapeutics Announces Pricing of Upsized $10.8 Million Underwritten Public Offering-
01.07.2021Windtree Appoints Diane Carman, Esq. as Senior Vice President and General Counsel
13.05.2021Windtree Therapeutics Reports First Quarter 2021 Financial Results and Provides Key Business Updates
19.04.2021Windtree Therapeutics Announces New Istaroxime Expedited Review Filing of Patent
29.03.2021Windtree Therapeutics Reports Fourth Quarter and Year End 2020 Financial Results and Provides Key Business Updates
25.03.2021Windtree Therapeutics Announces Closing of $30.0 Million Public Offering
23.03.2021Windtree Therapeutics Announces Pricing of $30.0 Million Public Offering
22.03.2021Windtree Therapeutics Announces Proposed Public Offering of Common Stock and Warrants
22.03.2021Windtree Extends Scientific Collaboration in Heart Failure Studying Its SERCA2a Activators with the University of Milan-Bicocca
16.02.2021Windtree Announces Issuance of New U.S. Patent Covering Technology on Its Redesigned AEROSURF® Device
Show more

Reviews 0

Sign up to leave a review

Sign up Log In